Detalhe da pesquisa
1.
A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma.
Oncologist
; 29(4): 324-331, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950901
2.
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis.
Future Oncol
; : 1-16, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647011
3.
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 24(4): 347-359, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868252
4.
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 24(11): 1252-1265, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844597
5.
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.
Kidney Int
; 104(3): 552-561, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343659
6.
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
Cancer
; 128(11): 2085-2097, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383908
7.
German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy.
Urol Int
; 106(5): 431-439, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144260
8.
Wnt/ß-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells.
Int J Mol Sci
; 23(10)2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628130
9.
Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines.
Int J Mol Sci
; 23(21)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362301
10.
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Int J Cancer
; 148(7): 1685-1694, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33070307
11.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 378(14): 1277-1290, 2018 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562145
12.
Prostatic Artery Embolization-Anatomic Predictors of Technical Outcomes.
J Vasc Interv Radiol
; 31(3): 378-387, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31735482
13.
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Future Oncol
; 16(29): 2307-2328, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32964728
14.
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.
Lancet Oncol
; 20(2): 297-310, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658932
15.
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
Lancet Oncol
; 20(10): 1370-1385, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427204
16.
Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection.
World J Urol
; 37(12): 2699-2705, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30911812
17.
Prostatic Artery Embolization with 250-µm Spherical Polyzene-Coated Hydrogel Microspheres for Lower Urinary Tract Symptoms with Follow-up MR Imaging.
J Vasc Interv Radiol
; 29(8): 1127-1137, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29910163
18.
Collection of real-world data on nivolumab's effectiveness in renal cell carcinoma: rationale for an observational study.
Future Oncol
; 14(11): 1023-1034, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325434
19.
Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.
Urol Int
; 101(1): 16-24, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719296
20.
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 18(3): 312-322, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131785